Clinical trial
Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)
NCT02735902 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions - an Open, Multicenter Randomized Controlled Trial With Two Parallel Arms (1:1)
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- January 19, 2024
- Enrollment
- 170 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
transcatheter aortic valve replacement